Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Cabergoline
Re query by Roberta Nelson, the following review may help:
Ahlskog et al: Arch Neur 1994;51:1236-1241
After prolonged treatment with levodopa (Sinemet), PD patients develop
fluctuations in symptoms ("on-off effect"). Whether these are due to the
drug or to progression of the disease is uncertain. In a test on 41
volunteers, the long-acting dopamine agonist cabergoline as adjunct
significantly improved motor performance. Effect lasts much longer than that
of bromocryptine or pergolide, permitting administration only once a day,
and it is well tolerated. Further testing is recommended.
(Cabergoline is not yet in PDR '95, but has been in literature since 1988,
as treatment for hyperprolactinemia, and later as a dopamine agonist.)
J. R. Bruman (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance
